The Alliance for Regenerative Medicine Announces Election of 2017 ARM Officers, Executive Committee and Board of Directors

WASHINGTON, DC--(Marketwired - Oct 11, 2016) -  The Alliance for Regenerative Medicine (ARM), announced today the election of the 2017 ARM Officers, Executive Committee and Board of Directors.

"ARM leadership reflects the geographical and technological diversity of our membership," said Morrie Ruffin, managing director of ARM. "We welcome these new slates of officers, directors and executive committee members; each has demonstrated direct involvement and active participation in ARM's activities and has made vital contributions to the advancement of this sector."

ARM Officer terms are typically two years, while the ARM Board of Directors and Executive Committee are held to an annual re-election or rotation process, with nominations and approval by the ARM membership and Board.

ARM 2017 Officers:

• Robert Preti - Co-Founder & President, PCT, a Caladrius Company; Senior Vice President, Manufacturing & Technical Operations and Chief Technology Officer, Caladrius Biosciences (ARM Chairman)
• Matt Patterson - President & CEO, Audentes Therapeutics (ARM Vice Chairman)
• Martha Rook - Head of Gene Editing and Novel Modalities, MilliporeSigma / EMD Millipore (ARM Secretary)
• Rahul Aras - Co-Founder, President & CEO, Juventas Therapeutics (ARM Treasurer)

ARM 2017 Executive Committee:

• Rahul Aras - Co-Founder, President & CEO, Juventas Therapeutics (also ARM Treasurer)
• Eduardo Bravo - Managing Director & CEO, TiGenix
• Doug Doerfler - President & CEO, MaxCyte
• Karen Kozarsky - President, Vector Partners
• Edward Lanphier - Founder & Chairman, Sangamo BioSciences (ARM ex-officio)
• Tom Novak - Vice President, Strategic Partnerships, Cellular Dynamics International / FUJIFILM
• Matt Patterson - President & CEO, Audentes Therapeutics (also ARM Vice Chairman)
• Robert Preti - Co-Founder & President, PCT, a Caladrius Company; Senior Vice President, Manufacturing & Technical Operations and Chief Technology Officer, Caladrius Biosciences (also ARM Chairman)
• Martha Rook - Head of Gene Editing and Novel Modalities, MilliporeSigma / EMD Millipore (also ARM Secretary)
• Jay Siegel - Chief Biotechnology Officer and Head, Scientific Strategy & Policy, Johnson & Johnson
• David Smith - Vice President, Global Business Development, Lonza
• Alexander Vos - CEO, PharmaCell

ARM 2017 Board of Directors: